BioCentury
ARTICLE | Financial News

Labopharm completes follow-on

February 15, 2010 8:00 AM UTC

Labopharm Inc. (TSX:DDS), Laval, Quebec Business: Drug delivery, Neurology Date completed: 2/12/2010 Type: Follow-on Raised: $20 million Units: 11.8 million Price: $1.70 (unit) Shares after offering: ...